Menu
Cancer Fund
Microsites Logo Cancer Fund

Cancer Fund

Investing in innovations for cancer treatment and prevention

  • Home

    Invest in the future of cancer diagnosis, treatment, and prevention
  • Home

    ~15-20 venture investments made over ~12-18 months — diversified by stage, geography, lead investor
  • Home

    Reserves ~25-33% to pursue follow-on opportunities in the most promising portfolio investments
  • Home

    Investments sourced by a team of dedicated investing professionals, our network of handpicked Scouts, AV’s 625K+ supporters, and other AV funds
  • Home

    Part of Alumni Ventures, America's Largest Venture Firm for Individuals and a "Top 20 Venture Firm" (CB Insights '24)

See video policy below.

8 Funds

8 Funds

distinct offerings

180K<sup>+</sup>

180K+

community members

1600<sup>+</sup>

1600+

investors

Figures represent 8 funds offered during 2022 and investors and community across all Focused Funds since inception.

AV’s Cancer Fund Advantages

  • Home

    Team of experienced investors with connections to entrepreneurs and innovators in the oncology field
  • Home

    Network of independent Scouts, sharing investment opportunities in various regions, subsectors
  • Home

    Network of 625K+ supporters who provide advice, referrals, connections
  • Home

    Robust support to entrepreneurs through our CEO Services
  • Home

    Interest and ability to support our most promising companies in follow-on rounds

Book A Private Intro Call

Quick & Easy. 15 Minutes.
Calls are intended for accredited investors only.

Cancer Fund News

Content at the intersection of entrepreneurship, venture capital, and specific industry sectors.

  • Sorry! Nothing matches that filter combination — try a broader search

Enter Secure Data Room

for key fund materials
  • Home

    Fund Information
  • Home

    Performance Data
  • Home

    Investor Rewards
  • Home

    Fund Policies

Meet the Team

  • Fund Team
  • AV Support Team

Sample AV Cancer Fund Deals

These investments, from AV's existing portfolio, are examples of the Cancer Fund's investing strategy.*

AIQ Solutions

Prediction platform on cancer treatment effectiveness

American Gene Technologies

Gene and cell therapy drugs

Clear Labs

Genomics-based testing & cutting-edge data science

miRecule

MicroRNA therapeutics to treat cancer

Ossium Health

Stem-cell therapeutics plus donor bone-marrow bank

ResistanceBio

Therapeutics for patients with treatment-resistant cancer

SHINE Technologies

Cost-effective, ecofriendly production of medical isotopes

Siris Medical

AI-enabled decisioning based on massive database analysis

SQZ Biotechnologies

Unlocking the full potential of cell therapies

SURGE Therapeutics

Guiding how, when, where cancer immunotherapy is deployed

*Investments are shown for illustrative purposes only, are not necessarily representative of any other AV fund or AV investor experience, and are not accessible to future investors, except potentially in the case of follow-on investment.

Access Fund Materials

  • Home
    Fund information
  • Home
    Performance data
  • Home
    Speak with our team

Ready to invest? Review fund materials, reserve your spot now or speak with our team.

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: info@av.vc

Press inquiries: press@av.vc

603-518-8112

Follow us

Neither Alumni Ventures nor any of its fund are sponsored by, affiliated with, or endorsed by any school. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see information on all AV fund investment performance, please see here. To see additional risk factors and considerations, please see here.

No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only pursuant to the formal offering documents for the funds concerned, which describe the risks, terms, and other important information that must be carefully considered before an investment is made. Alumni Ventures and its affiliates provide advice only to venture capital funds affiliated with AV. No information on this website may be relied upon as personalized advice to any recipient.

Please see Alumni Ventures’ Legal & Privacy Policy here and additional Investor Policies here.

Testimonial/Endorsement Policy: Testimonials and Endorsements were provided without compensation but each provider has a relationship with AV from which they benefit. Management of portfolio companies have received, and may in the future receive, investments from AV, which constitutes a conflict of interest. All views expressed are the speaker’s own. The providers of the testimonials/endorsements were not selected on objective or random criteria, but rather were selected based on AV’s understanding of its relationship with the providers of the testimonials/endorsements. The testimonials and endorsements do not represent the experience of all AV fund investors or all companies in which AV funds invest.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose.

Co-investors: Co-investors are shown for illustrative purposes only, do not reflect the universe of all organizations with which AV has co-invested, and do not necessarily represent future co-investors. The identity of a co-investor does not necessarily indicate investment quality or performance.

© 2025, Alumni Ventures. All rights reserved.